Vimian Group AB (publ) (VIMGF)
OTCMKTS
· Delayed Price · Currency is USD
4.255
+0.265 (6.64%)
At close: Jul 2, 2025
Vimian Group AB Market Cap
Vimian Group AB has a market cap or net worth of $2.33 billion as of July 10, 2025. Its market cap has increased by 34.47% in one year.
Market Cap
2.33B
Enterprise Value
2.53B
Revenue
422.61M
Ranking
n/a
PE Ratio
111.82
Stock Price
$4.26
Market Cap Chart
Since June 18, 2021, Vimian Group AB's market cap has decreased from 3.65B to 2.33B, a decrease of -36.02%. That is a compound annual growth rate of -10.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 2.33B | 23.72% |
| Dec 30, 2024 | 1.89B | 40.53% |
| Dec 29, 2023 | 1.34B | 23.45% |
| Dec 30, 2022 | 1.09B | -68.17% |
| Dec 30, 2021 | 3.41B | -6.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 798.20M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 613.26M |
| Elite Pharmaceuticals | 610.04M |
| American Oncology Network | 430.54M |
| CytoDyn | 391.14M |